Director of National Intelligence Tulsi Gabbard announced that her office has uncovered evidence showing the U.S. government funded more than 120 biological laboratories operating in over 30 countries. According to Gabbard, the findings emerged after months of reviewing intelligence community records and internal government files. She said some laboratories conducted research involving hazardous pathogens, while others conducted gain-of-function studies, a type of research that examines how viruses and other pathogens may become more transmissible or dangerous.

Gabbard stated that intelligence assessments had previously identified at least one U.S.-funded laboratory in Ukraine that housed potentially dangerous pathogens and was considered vulnerable during the country’s ongoing conflict with Russia. She asserted that the existence and scope of these laboratories had not been fully disclosed to the public and accused previous government officials of withholding information about their funding and activities.

The announcement comes as the Trump administration continues to scrutinize gain-of-function research and biosecurity policies as a whole. Gabbard linked the findings to President Trump’s efforts to halt federal funding for gain-of-function research worldwide and said intelligence agencies have been directed to increase monitoring of overseas biological laboratories. She also pledged continued investigations into the locations, activities, and research conducted at these facilities, citing concerns related to public health and national security.

Gabbard’s findings touch on several contentious issues that have been the source of intense public debate since the COVID-19 pandemic. The government’s role and transparency in biological research on dangerous pathogens have often been defended as ways to better understand potential disease threats and improve preparedness…

The White House signed an executive order on flying cars. The FAA created new Light Sport Aircraft rules. And Doroni Aerospace just became one of the first personal eVTOLs approved for manned testing.*

Their H1-X personal aircraft fits in your garage, charges like an EV, and flies 120 mph for 100 miles. It’s designed for everyday life, not professional pilots, requiring just 25 hours of training to operate its intuitive joystick controls.

They just unveiled the full-scale showroom prototype, a milestone 9 years coming. In that time, they saw 600+ pre-orders, $240M+ in potential revenue, and $14.5M+ in capital raised from 5,500+ investors.

Now they’re tracking to begin delivering H1-X units by 2028. And you can claim an early-stage stake in Doroni at $3.10/share today. But hurry. Invest in Doroni before the June 18 deadline.

However, these methods have been widely criticized, as many believe that certain forms of research, particularly gain-of-function research, pose risks when safety protocols fail or sensitive materials are mishandled.

According to Gabbard, the intelligence review identified more than 120 U.S.-funded laboratories operating in over 30 countries. Those figures are likely to raise questions about how these facilities are monitored and the research being conducted, as well as the level of oversight when projects are funded outside the United States.

The Trump administration has already moved to restrict federal funding for gain-of-function research, and the newly released information may strengthen calls for additional safeguards and oversight measures.

Much of the research discussed in the announcement was funded with taxpayer dollars, meaning Americans have a vested interest in how these projects are managed, what safeguards are in place, and how much information is made available to the public. These types of labs and the research being done in them have been a sensitive subject since the pandemic, and the findings are likely to put pressure on government agencies to provide clearer explanations regarding their purpose and funding moving forward.

Public trust in institutions has eroded since the pandemic, especially for public health entities. While public confidence has increased slightly over the last few years, public trust has yet to return to pre-pandemic levels. The questions raised by this intelligence review are likely to fuel debates over government transparency and who should ultimately oversee this type of research, given the catastrophic consequences at stake.

*Disclaimer: This is a paid advertisement for Doroni Regulation A offering. Please read the offering circular at https://invest.doroni.io/